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Abstract 
 
Oligodendrocytes are the myelinating cells of the central nervous system. The 
extraordinary protein and lipid synthesis that myelin production entails makes oligodendrocytes 
especially prone to endoplasmic reticulum (ER) stress. In this experiment, we set out to 
investigate the dynamics of ER stress in mixed glial cultures, and how the consequences of that 
stress vary based on the activity of the anabolic PI3K/AKT/mTOR pathway. Previous 
experiments in isolated oligodendrocyte cultures demonstrated a negative correlation between 
AKT/mTOR signaling and oligodendrocyte cell viability in the presence of ER stressors. 
Because ER stress leads to a buildup of improperly processed proteins, decreases in mTOR 
pathway activity are thought to moderate the excess of misfolded polypeptides. We hypothesized 
that administration of rapamycin, an inhibitor of mTOR, would ameliorate the effects of ER 
stress by preventing protein buildup caused by mTOR pathway activity. To test this hypothesis, 
mixed cultures of oligodendrocytes and astrocytes were isolated from neonatal rat brains and 
exposed to tunicamycin (TU), an inhibitor of n-linked glycosylation, to induce ER stress. TU 
was administered alone and after pre-treatment with rapamycin, to investigate how the effects of 
ER stress change when the activity of that pathway was limited. By assaying cell survival and 
protein expression, we were able to determine how ER stress, with and without mTOR 
inhibition, affected cell populations in mixed glial cultures. We found that chronic TU exposure 
in the absence of rapamycin failed to decrease the percentage of oligodendrocyte-lineage cells, 
which we attribute to the protective effects of astrocytes. Acute exposure, however, did decrease 
the percentage of oligodendrocyte-lineage cells in culture. These two trends lead us to speculate 
that the protective effects astrocytes offer to oligodendrocytes consist of relatively slow-acting 
growth-factor production and secretion by astrocytes. Adding strength to this contention, we 
found that the mTOR inhibitor rapamycin did not increase the percentage of oligodendrocyte-
lineage cells in cultures exposed to TU. Because mTOR is involved in the function of many 
growth factors, its inhibition may have hampered the protective functions of astrocytes. While 
other experiments have investigated the effects of ER toxins on activity of the mTOR pathway, 
this experiment is more faithful to in vivo conditions because it incorporates meaningful 
astrocyte-oligodendrocyte interactions. As observed in this experiment, these effects are 
powerful and serve to improve our understanding of the dynamics of ER stress and mTOR 
inhibitors in organismal glial cells. 
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Introduction 
 
 The human central nervous system (CNS) – and by extension the mind to which it gives 
rise – is composed of two categories of cells: neurons and neuroglia. Neurons tend to receive a 
disproportionate amount of attention, as they execute the electrically-mediated cellular 
communication that affords sensation, movement, and cognition (Kiernan, 2009). However, 
neuroglia – a category that includes ependymal cells, microglia, astrocytes, and oligodendrocytes 
– constitute over half of the CNS cellular population and perform duties that are as diverse as 
they are essential (Bercury and Macklin, 2015; Kiernan, 2009).  
 These duties are described in Kiernan’s The Human Nervous System: An Anatomical 
Viewpoint, where the author comprehensively reviews the responsibilities of each type of 
neuroglia (2009). Astrocytes serve to maintain homeostasis, improve synaptic transmission by 
preventing diffusion of neurotransmitters, and secrete antioxidants and growth factors. 
Ependyma border the brain’s ventricles, allowing for molecular exchange between cerebrospinal 
fluid and nervous tissue. Microglia function as phagocytes when triggered by inflammation, and 
thereby protect the nervous system from potential disease. Finally, oligodendrocytes are 
responsible for the myelination of the CNS.  
 The importance of the role of oligodendrocytes – and of myelin more specifically – can 
hardly be overstated. Found to have convergently evolved in a variety of taxa, myelin is a lipid 
membrane that envelops the exterior of axons (Hartline, 2008). In doing so, it acts as an 
electrical insulator, preventing signal leakage as an impulse travels from one neuron to another. 
Additionally, the presence of myelin reduces the radial capacitance of axons, and as a result 
allows for greater conduction speed (Hartline, 2008). More recent research suggests that myelin 
also provides metabolic support to axons; when performing aerobic glycolysis, oligodendrocytes 
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produce lactate that can be metabolized by nearby axons (Bercury and Macklin, 2015). As a 
consequence of its utility, any absence or damage to myelin – demyelination – can have 
profoundly negative effects on the brain.  
 These negative effects have been implicated in a wide variety of disorders. The most 
infamous, and common, disease associated with demyelination is multiple sclerosis (Mayo et al., 
2012). Other diseases associated with dysmyelination include psychiatric disorders like autism 
spectrum disorder, sensory processing delay disorder, and attention deficit hyperactivity 
disorder; neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease, and 
amyotrophic lateral sclerosis; and rarer diseases including neuromyelitis optica and acute 
disseminated encephalomyelitis (Mayo et al., 2012; Bercury and Macklin, 2015). These 
demyelinating pathologies stem from more factors than damage to oligodendrocytes alone, but 
that damage can contribute to disease progression. For instance, in animal models of multiple 
sclerosis, preventing oligodendrocyte cell death improves disease prognosis by reducing 
demyelination and the degradation of axons (Hussein et al., 2014). Thus, oligodendrocyte 
survival and health is a key component of outcomes in diseases involving demyelination. 
Knowing how to treat such disorders will require leveraging knowledge about oligodendrocytes 
and myelination, and the ways in which the two can be preserved in the face of stressors. 
 The foundation of this knowledge consists of a wealth of information on oligodendrocyte 
growth and development. Oligodendrocytes originate as oligodendrocyte progenitor cells, which 
constitute roughly 5% of all glial cells in the adult brain (Levine et al., 2001). Their subsequent 
development into mature cells relies on various cellular signaling cascades including the 
Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways (Guardiola-Diaz et al., 2012). The 
Ras/Raf/MEK/ERK pathway, also known as a mitogen-activated protein kinase pathway, is able 
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to integrate extracellular signals via G-protein activation, culminating in phosphorylation activity 
that can alter rates of cellular growth and proliferation (Kolch, 2000). Much like the 
Ras/Raf/MEK/ERK pathway, the PI3K/AKT/mTOR pathway regulates cellular growth and 
homeostasis based on the integration of a variety of internal and external signals (Wood et al., 
2013). Because each pathway is involved in regulating cellular growth, each plays a role in the 
life cycle of oligodendrocytes, which is summarized in Figure 1. 
 The first transition oligodendrocyte progenitors make is from early progenitor cells, 
which demonstrate a bipolar morphology, into late progenitor cells, which have more extensions 
and form a multipolar organization (Guardiola-Diaz et al., 2012). In each case, the cells express 
the lipid antigen A2B5, while only late progenitors express the lipid antigen O4, allowing 
researchers to distinguish between early and late progenitor cells (Guardiola-Diaz et al., 2012). 
When researchers inhibited downstream signaling of the Ras/Raf/MEK/ERK pathway using the 
Mek inhibitor U0126 and used this lipid antigen identification method, they found that the early 
to late progenitor transition was blocked (Guardiola-Diaz et al., 2012). This blockage did not 
occur when the PI3K/AKT/mTOR pathway was inhibited with rapamycin, indicating that ERK 
signaling plays a unique regulatory role in the early to late progenitor transition (Guardiola-Diaz 
et al., 2012). Following the late progenitor stage, there is postmitotic terminal differentiation to 
the immature oligodendrocyte stage, again partially regulated by ERK signaling (Guardiola-Diaz 
et al., 2012). Immature oligodendrocytes then proceed to the mature oligodendrocyte stage – 
during this process they develop the numerous axonal connections that characterize a terminally 
differentiated oligodendrocyte (Guardiola-Diaz et al., 2012). This last transition fails to occur 
when mTOR is inhibited using rapamycin, but occurs despite ERK inhibition, suggesting that the 
mTOR pathway is the unique regulator of the immature to mature stage of oligodendrocyte 
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differentiation (Guardiola-Diaz et al., 2012). Interestingly – and usefully – throughout their life 
cycle, oligodendrocytes express the Olig2 transcription factor, which offers a reliable means of 
identifying oligodendrocyte-lineage (OL-lineage) cells in every developmental stage (Guardiola-
Diaz et al., 2012). 
 Once at the mature stage, oligodendrocytes are typically quite stable: research in the adult 
human nervous system using carbon-14 labeling found that only one in 300 oligodendrocytes is 
replaced over the course of a year (Yeung et al., 2014). The same study found that myelin has a 
high turnover rate even in adults, indicating that mature oligodendrocytes continue to replenish 
myelin throughout the lifespan of an organism. This is a formidable task, if only because of the 
number of connections a myelinating cell makes with the axons around it: mature 
oligodendrocytes may form up to 50 internodes with adjacent axons (Pfeiffer et al., 1993). These 
internodes are extensions of the oligodendrocyte’s plasma membrane, which envelops 
neighboring sections of axons. This sheath performs the insulating duties that contribute to 
greater impulse speed, and its structure and composition are essential for its function: myelin is 
70% lipid (Pfeiffer et al., 1993). 
 The lipid-rich structure of myelin makes its synthesis extremely dependent on certain 
cellular organelles and processes. In particular, the formation of myelin relies on the 
endoplasmic reticulum (ER). The ER is an organelle that consists of tubules, sacs, and cisternae 
that extend from the cytoplasm to the nuclear envelope (Sovolyova et al., 2014). When the ER 
functions properly, it performs three vital roles (Lin and Popko, 2009). First, it processes the 
majority of the cell’s proteins, governing the post-translational modification and folding that are 
integral for a protein’s structure and therefore its function. Second, it oversees the synthesis of 
lipid molecules, including steroids and cholesterol. Third, it regulates cytoplasm calcium 
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concentrations by either taking up or releasing the ion depending on its intracellular 
concentration. Because of its role in producing the elements that are necessary parts of myelin, a 
dysfunctional ER limits or eliminates entirely the ability of an oligodendrocyte to myelinate. As 
a result, demyelinating disorders often stem from or involve the malfunction of the ER (Zhang 
and Kaufman, 2008). This failure in function can result from various mechanisms, but one of the 
most common triggers is a phenomenon known as ER stress (Schroder and Kaufman, 2005). 
 The ER is most likely to become stressed when there is a disturbance in its homeostasis 
(Lin and Popko, 2009). These disruptions can consist of changes in calcium, glucose, cholesterol, 
or oxidation status; in elevated rates of protein synthesis; or when glycosylation is inhibited (Lin 
and Popko, 2009; Yoshida, 2007). If its homeostasis is sufficiently disturbed, the ER loses its 
ability to properly fold proteins (Lin and Popko, 2009). As a result, misfolded proteins collect in 
the lumen of the organelle – it is this accumulation that is the ultimate sign of ER stress (Lin and 
Popko, 2009). For oligodendrocytes, ER stress is mostly likely to occur during periods of myelin 
development or repair (Hussein et al., 2014). This is because myelination puts an immense load 
on the protein-folding capacities of the ER, and as this load approaches the capacity of the 
organelle, stress becomes an increasingly likely outcome. 
 Fortunately, the ER is not defenseless in the face of stress. Rather, the cell can execute 
unique responses meant to address and remediate the effects of that stress in a therapeutic 
manner (Walter and Ron, 2011). These responses consist of several signal transduction pathways 
and are together known as the Unfolded Protein Response, or UPR, which is summarized in 
Figure 2 (Walter and Ron, 2011). Each of these pathways begins with one of three 
transmembrane receptors, described below, which are, in the absence of stress, inactive (Walter 
and Ron, 2011). But as proteins accumulate in the ER lumen, indicating the onset of stress, each 
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of these transmembrane receptors is activated (Sovolyova et al., 2014). Their activation induces 
the downstream signaling cascades that serve as the UPR (Sovolyova et al., 2014). 
 The consequences of the UPR depend on the intensity and duration of ER stress 
(Sovolyova et al., 2014). In the presence of mild or short-lived stress, the effect of the UPR is to 
prolong cell survival (Kapuy et al., 2014). Conversely, when stress is especially exaggerated or 
long-term, the continued activation of the UPR leads to apoptosis (Kapuy et al., 2014). As these 
two polar outcomes both rely on the UPR, the ability of the cell to choose the correct path based 
on cellular conditions is, quite literally, an issue of life and death. 
 In the event of mild, short-term stress, the UPR exerts five positive effects. First, it 
prevents the translation of non-essential proteins, given the excess amount already present in the 
lumen (Schroder and Kaufman, 2005). Second, it ramps up the process of ER-associated 
degradation (ERAD) in order to destroy some of those excess, misfolded proteins (Duffee et al., 
2012). Third, it induces the formation of autophagosomes and upregulates the process of 
autophagy in order to digest additional unwanted cellular material (Benbrook and Long, 2012). 
Fourth, it leads to translational changes that increase the number of molecular chaperones, which 
aid in protein folding (Walter and Ron, 2011). Fifth, it expands the area of the ER membrane in 
order to facilitate the work of those new chaperones and the creation of new, functional 
polypeptides (Walter and Ron, 2011).  
 Three signal cascades are sufficient to produce these potentially cell-saving processes, 
and the responsibility and mechanism of each has been well-studied. Each of the cascades begins 
at one of three transmembrane receptors: protein kinase RNA-like ER kinase (PERK), activating 
transcription factor 6 (ATF6), or inositol-requiring enzyme 1 (IRE1) (Walter and Ron, 2011). 
Each of these transmembrane proteins has a luminal domain that serves to detect ER stress, and a 
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cytosolic domain that can trigger changes in cellular activity in response to that stress (Cao and 
Kaufman, 2012).  
 Of the three transmembrane proteins, IRE1 is the oldest and most conserved (Walter and 
Ron, 2011). When the lumen becomes crowded with misfolded proteins, luminal binding protein 
– known as BiP – detaches from the IRE1 protein and binds with those misfolded proteins 
(Duffee et al., 2012). As a result, IRE1 is activated and catalyzes the removal of an intron from 
the mRNA that codes for a protein called X-box binding protein 1 (XBP-1). This deletion leads 
to a frameshift in the coding sequence, producing a different isoform of XBP-1.The new isoform 
of XBP-1 increases the expression of several different proteins responsible for protein folding 
and degradation. As a result, the ER is able to fold future polypeptides while disposing of those it 
has misfolded in the past. Meanwhile, IRE1 activation also activates the c-Jun N-terminal kinase 
(JNK) pathway, which lipidates microtubule-associated protein 1A/1B-light chain 3 (LC3), 
altering it from LC3-1 into LC3-II (Szegezdi et al., 2006; Tanida et al., 2008). Lipidated LC3-II 
is incorporated into the membrane of autophagosomes, which then proceed to increase the 
amount of autophagy in the cell (Benbrook and Long, 2012). 
 The second oldest transmembrane protein in the UPR is ATF6 (Duffee et al., 2012). 
When ER stress occurs, ATF6 is moved into transport vesicles that move it to the Golgi 
apparatus (Walter and Ron, 2011). There it meets two proteases, S1P and S2P (named for the 
sites at which they are located), which sequentially remove the ATF6 luminal domain and 
transmembrane anchor. This leaves a transcriptional domain known as ATF6(N) that moves into 
the nucleus and upregulates various UPR stress genes, including those that code for molecular 
chaperones like protein disulfide isomerase (PDI) and glucose-regulated protein 94 (Grp94) 
(Walter and Ron, 2011; Duffee et al., 2012). ATF6 activation also leads to an increase in the 
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production of degradation proteins, including ER degradation-enhancing alpha-mannosidase-like 
protein 1 (EDEM1) (Duffee et al., 2012). Just as with IRE1, activation of ATF6 allows for the 
efficient disposal of undesired proteins and the creation of new, fully operational proteins to take 
their place.  
 The final, most evolutionarily recent transmembrane protein in the UPR is PERK (Duffee 
et al., 2012). When activated by the accumulation of misfolded proteins in the lumen, PERK 
phosphorylates a subunit of the translation initiation factor eIF2α, preventing it from initiating 
the translation of select proteins from mRNA (Duffee et al., 2012). Thus, activation of PERK 
leads to a decrease in the translation of non-essential proteins (e.g., those not involved in protein 
degradation and folding) and gives the ER a critical period during which it can dispose of those 
already amassed inside of the lumen (Walter and Ron, 2011). Along with the other two signal 
cascades of the UPR, led by IRE1 and ATF6, PERK serves to give the ER the time and 
molecular machinery necessary to combat stress. 
 While the UPR promotes autophagy in cases of mild stress, more intense or enduring 
stress can cause the UPR to become pro-apoptotic. This switch means that the same 
transmembrane proteins that previously promoted cell survival become promoters of apoptosis. 
IRE1, for example, triggers the apoptosis signal-regulating kinase 1 pathway in the event of 
long-term stress (Duffee et al., 2012). Interestingly, intense stress also turns a positive effect of 
IRE1 during mild stress – upregulation of the JNK pathway that promotes a healthy level of 
autophagy – into a negative effect that can lead to apoptosis. This shift occurs through the 
downstream phosphorylation of a protein known as Bcl-2 (Szegezdi et al., 2006). Bcl-2 usually 
demonstrates anti-apoptotic activity; phosphorylation inhibits this activity and apoptosis 
therefore becomes more likely (Szegezdi et al., 2006). The PERK signaling pathway can also 
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promote cell death; this process occurs via activation of the transcription factor 
CCAAT/enhancer-binding homologous protein (CHOP) (Lu et al., 2014). In one experiment that 
assessed the role of CHOP in ER stress, oligodendrocyte progenitor cells isolated from rats were 
more likely to survive when a chemical inhibitor of CHOP, amiloride, was administered 
(Kuroiwa et al., 2014). A related study, which used CHOP-knockout mice in order to investigate 
spinal cord injury recovery, found that the prognosis for CHOP-knockout mice was greatly 
improved relative to controls, with increased white matter and myelin basic protein testifying to 
increased oligodendrocyte survival (Ohri et al., 2013). The negative effects of CHOP on cell 
survival are believed to relate to its upregulation in the transcription of the death receptor 5 gene 
(Lu et al., 2014). During acute ER stress, this increased transcription is not sufficient to lead to 
apoptosis, because the IRE1 signal cascade leads to the decay of death receptor 5 mRNA (Lu et 
al., 2014). However, as stress duration increases the likelihood of apoptosis does as well, since 
the upregulation of death receptor 5 begins to outpace its destruction. 
 In addition to the complex cascades described above, the UPR maintains a nuanced 
relationship with the PI3K/AKT/mTOR pathway (Appenzeller-Herzog and Hall, 2012). mTOR, 
or mammalian target of rapamycin, is  a serine/threonine protein kinase that is often referred to 
as a master regulator, since it incorporates inputs including growth factors, amino acid and 
glucose levels, and energy stores in order to control the rates of growth and metabolism in a cell 
(Wood et al., 2013; Kapuy et al., 2014). Generally, mTOR can be said to have anabolic effects 
on a cell, which include the upregulation of protein production and the downregulation of 
autophagy via phosphorylation of a compound known as Atg13, which is required in its 
dephosphorylated state for autophagosome production (Eisenberg-Lerner et al., 2009; Jung et al., 
2010; Sano and Reed, 2013). During very short-term stress, the UPR activates 
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PI3K/AKT/mTOR signaling via the ATF6 pathway (Appenzeller-Herzog and Hall, 2012). This 
takes advantage of the role that mTOR plays in promoting growth, allowing the cell to perform 
certain anabolic processes that are conducive to cell survival, such as ER membrane expansion 
and the synthesis of molecular chaperones. However, during longer term stress the UPR inhibits 
the mTOR pathway through PERK-mediated activation of CHOP, which induces the synthesis of 
an AKT inhibitor known as TRB3, and therefore results in a downstream decrease in mTOR 
signaling (Appenzeller-Herzog and Hall, 2012). This inhibition helps to prevent apoptosis, since 
the mTOR pathway would otherwise increase the likelihood of cell death by stimulating high 
levels of JNK via activation of IRE1 (Appenzeller-Herzog and Hall, 2012). The inhibition of 
mTOR by the UPR has been shown experimentally: in work with mouse embryonic fibroblasts, 
Qin et al. found that extended UPR activation leads to decreased signaling from the AKT/mTOR 
pathway (2010).  
 Lowered mTOR signaling in response to extended UPR activation has the beneficial 
consequence of increasing autophagy in stressed cells, since active mTOR is anti-apoptotic. This 
finding has been confirmed both theoretically and experimentally. Using neuroblastoma cells, 
Ogata et al. found that ER stress led to an increase in the rate of autophagosome formation in a 
cell (2006). In another experiment, this time using human kidney cells, the same upregulation of 
autophagosome production in response to ER stress was observed (Kapuy et al., 2014). Because 
this increase in autophagy leads to the digestion of unwanted cellular material and a reversion 
towards ER homeostasis, the UPR’s inhibition of the AKT/mTOR pathway can very well be said 
to serve as a cytoprotective process. 
 While mTOR inhibition by the UPR can, along with the other arms of the UPR, help in 
preventing apoptosis, it sometimes is not a sufficient response. This insufficiency is illustrated in 
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the high rates of cell death that often accompany ER stress (Sano and Reed, 2013). To try to 
address this inadequacy, some researchers have investigated the possibility of artificially 
inhibiting mTOR and thereby effectively accelerating and intensifying the effects of the UPR. 
Fortunately, there are various chemicals that serve as mTOR inhibitors, including two 
compounds known as rapamycin and metyrapone (Faivre et al., 2006; Kapuy et al., 2014). 
Several experiments have investigated the effects of administering these inhibitors in conditions 
of ER stress. In one such study, administration of rapamycin to stressed human kidney cells led 
to the onset of autophagy at lower levels of stress than in control cells (Kapuy et al., 2014). 
Autophagy was also found to continue at higher levels of stress than in control levels, suggesting 
that artificial mTOR inhibition was delaying apoptosis by prolonging autophagy (Kapuy et al., 
2014). In a similar study, Kato et al. induced ER stress in rat kidney cells using tunicamycin 
(TU), which inhibits n-linked glycosylation of secretory and membrane proteins and thus renders 
the protein-folding process more difficult (2012). Some of the ER stressed cultures had been pre-
treated with rapamycin, while others only received the ER stressor. The researchers found that 
rapamycin-exposed cells were less likely to die than those that were only exposed to TU. Other 
findings, using monkey kidney cells and mouse β-cells, demonstrate an identical pattern: the 
upregulation of autophagy can prevent ER stress-induced apoptosis (Ravikumar et al., 2006; 
Bachar-Wikstrom et al., 2012). Ameliorating ER stress through other means also has positive 
effects. In oligodendrocyte progenitor cells given TU, cannabidiol treatment prevented apoptosis 
by blocking ER stress and subsequent activation of CHOP, while promoting expression of Bcl-2, 
an anti-apoptotic protein (Mecha et al., 2012). 
 While the literature includes various examples of mTOR inhibition in cases of ER stress, 
only certain cell lines have been studied. One overlooked cell has been the oligodendrocyte. In 
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some ways this is especially misguided, since oligodendrocytes are considered the most 
vulnerable cells in the CNS and are especially vulnerable to oxidative stress and inflammation 
(Benjamins et al., 2013; Johnstone et al., 2013). Though some research exists that aims to clarify 
the response of oligodendrocytes to ER stress (e.g. Mecha et al., 2012), far fewer studies assess 
the potential for artificial mTOR inhibition in those cells.  
 A further gap in the literature relates to the fact that oligodendrocytes tend to be studied 
in enriched cultures. An example of these enriched studies can be seen in previous work done by 
this lab. In this research, enriched cultures of two-day-old oligodendrocyte progenitors were 
exposed to TU at different concentrations and for different periods (McInnis, 2012). Cell 
viability was assayed using alamarBlue fluorescence, which offers a measurement of cell 
survival. Significant drops in cell survival were observed after a 3 hour acute treatment with 10 
µg/ml of TU (Figure 3), as well as for 12 hour chronic treatments at 2 µg/ml (Figure 4). 
However, while enriched culture data tends to be convenient to collect, it fails to approximate in 
vivo conditions, where the presence of other cells influences oligodendrocyte behavior and 
response to ER stress. 
 In order to address these gaps in the literature, the present study will study whether ER 
stress is affected by mTOR inhibition in mixed glial cultures. In this experiment, the effects of 
rapamycin pre-treatment on mixed glial cultures undergoing ER stress will be analyzed. ER 
stress will be induced using TU, the inhibitor of N-linked glycosylation discussed above for its 
role as an ER stressor. This stress will be induced in various time points and concentrations, in 
order to assess whether any effects of rapamycin are more pronounced for a given stress 
condition.  
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 We hypothesize that by reducing protein production and stimulating autophagy, artificial 
inhibition of the mTOR pathway via rapamycin pre-treatment will help to improve 
oligodendrocyte viability for all mixed glial cultures exposed to ER stressors. If this is the case, it 
would raise interesting questions about the potential to address certain disorders of myelination 
that involve ER stress with mTOR inhibitors in order to preserve oligodendrocyte populations. 
We further hypothesize that overall toxicity as a result of TU exposure will be lowered relative to 
similar experiments conducted in enriched cultures, such as that of McInnis (2012). We 
hypothesize that the protective effects exerted by glia, astrocytes especially, will improve 
oligodendrocyte viability during ER stress. For instance, astrocytes protect oligodendrocyte 
progenitors from oxidative stress-induced damage and nutrient starvation, while also protecting 
mature oligodendrocytes in the event of CNS injury (Arai and Lo, 2010; Sofroniew, 2005). 
Astrocyte presence alters oligodendrocyte fate, and experiments that fail to account for this 
inherently fail to approximate physiological conditions. Using mixed cultures, on the other hand, 
will incorporate the contributions of astrocytes to the oligodendrocyte stress response. 
 Our experimental paradigm, therefore, is more physiologically relevant than those that 
have preceded it. We believe that our data will allow for more credible extrapolations of our 
experimental data onto questions concerning how oligodendrocytes behave in an organism. This 
extension is important, and carries high stakes. Because the activity of oligodendrocytes – and 
therefore the myelination of the brain – depends on a functional ER, it is critical to understand 
how oligodendrocytes respond to a stressed ER and whether their response can be helped 
through the artificial inhibition of certain pathways. By assessing whether rapamycin 
administration can ameliorate the negative effects of ER stress in oligodendrocytes, we will gain 
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insight into potential therapies for the otherwise devastating demyelination and dysmyelination 
that underlie many varied diseases.  
 However, even if we find that mTOR inhibition lessens some of the damage caused by 
ER stress, it is important to note that such a solution can only be temporary. This is because 
mTOR activity is required for much of a cell’s most important functions, including myelination. 
Several studies have shown that mTOR inhibition results in delayed onset of myelination and 
reduced total myelination (Guardiola-Diaz et al., 2012; Tyler et al., 2009; Lebrun-Julien et al., 
2014). Meanwhile, upregulation of mTOR increases overall myelination (Tyler et al., 2009; 
Lebrun-Julien et al., 2014). While mTOR activity may be fatal for a stressed cell, it is also 
necessary for a functional one. Any solution that involves mTOR inhibition, therefore, must 
include a point after which mTOR is allowed to function as normal. 
 An additional caveat concerns the cascading nature of cellular pathways. The 
administration of an mTOR inhibitor will produce more widespread effects than mTOR 
inhibition alone. The mTOR pathway has relationships with various other pathways, which 
interface with even more pathways, and so on (Hay and Sonenberg, 2004). Therefore, inhibiting 
mTOR will not simply lower rates of transcription and translation – it will also lead to greater 
activation of pathways for which mTOR is inhibitory, and less activation of pathways for which 
mTOR is excitatory (Dai et al., 2014). Therefore, the results produced in this experiment will be 
the consequence of not only one cellular change, but of one that precipitates many more. Teasing 
out these changes – in addition to observing the outcome to which they lead – is important, and 
may well be aided by data from the experiment described herein. 
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Materials and Methods 
 
Preparation of Mixed Glial Cell Cultures 
 
 To establish mixed glial cultures, neonatal rat pups (P2) were sacrificed via rapid 
decapitation according to IACUC approved protocol. Heads were transferred to a sterile 
dissection fume hood, where sterile surgical tools were used to remove the brain, which was 
placed in Hepes-EBSS buffer (HE) on ice.  
 The hindbrain and olfactory bulb of each brain were removed and the remaining 
telencephalon was divided into its two hemispheres. The telencephalic hemispheres were rolled 
on filter paper to remove the meninges and blood vessels, transferred to HE, and minced using a 
sterile razor held with locking tweezers. The solution of minced tissue was transferred to a 100 
ml solution of trypsin-HE and placed in a shaker at 110 RPM for 20 minutes at 37°C.  
 To terminate trypsinization, 2 ml of trypsin inhibitor (SBTI) was added to the beaker of 
minced tissue, which was swirled for two minutes at room temperature. Next, 2 ml of MgSO4 
was added to the solution, followed by 1 ml of DNAse stock at a concentration of 2 mg/ml. The 
resulting solution was incubated for five minutes at room temperature with gentle swirling. After 
this period, the tissue solution was transferred in four 50 ml sterile conical tubes, which were 
centrifuged for one minute at 2000 RPM. Supernatants were carefully aspirated and discarded, 
leaving a pellet at the bottom of each tube. Each pellet was resuspended in 5ml of trituration 
DNAse at a concentration of 80 of µg/ml, then allowed to settle for 5 minutes.  
 Each of the four resuspensions was transferred into a 15 ml sterile conical tube, and 1 ml 
of 4% BSA was added to each tube underneath the layer of tissue solution in order to form a 
density gradient. The four 15ml conical tubes were centrifuged for 8 minutes at 800 RPM. 
Supernatants were carefully aspirated and discarded, leaving a pellet at the bottom of each tube 
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covered by a shallow layer of fluid. Pellets were resuspended by tapping the tube and 5 ml of 5% 
fetal bovine serum (FBS) was added to each tube. The contents of each tube were then added to a 
sterile 125 ml bottle containing 30 ml of 5% FBS. Using a hemacytometer, the cell density of the 
solution was calculated. This solution was added to the prepared poly-lysine coated four-well 
plates – each well was seeded with 500,000 cells, and 5% FBS was added as needed to finalize 
the volume of each well at 0.5 ml. After each well was seeded, all plates were placed in a sterile 
incubator at 37°C. 
 
Care of Mixed Glial Cultures and ER Stress Induction 
 
 After four days in vitro, during which cells were allowed to divide and proliferate, the 
media was replaced with 0.5 ml of 5% fetal bovine serum, which inhibits cellular differentiation. 
Three days after the first media change, a second media change was performed. Three days after 
the second media change, each well was switched to N2 supplement media, which allows for 
cellular differentiation. This day was termed differentiation day 0. During this process, each well 
was divided into one of two groups: one that received N2 media with rapamycin at a 
concentration of 1 µl/ml (the rapamycin pre-treatment group), and one that received only N2 
media (the control group to which rapamycin pre-treatment would be compared). It is important 
to stress that rapamycin has been shown to not interfere in the differentiation process for early 
progenitor cells through immature oligodendrocytes (Guardiola-Diaz et al., 2012).  
 In our control paradigm, N2 media was replaced on differentiation day 1, 24 hours prior 
to harvest, with rapamycin pre-treatment wells also receiving 1 µl/ml rapamycin. In our chronic 
stress paradigm, 1 µg/ml TU was added on differentiation day 1, 24 hours prior to harvest, with 
rapamycin pre-treatment wells again receiving 1 µl/ml rapamycin. In our acute stress paradigm, 
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10 µg/ml TU was added on differentiation day 2, exactly 3 hours prior to harvest, with 
rapamycin pre-treatment wells again receiving 1 µl/ml rapamycin. Once the treatment time 
elapsed, cells were harvested to allow for immunohistochemistry. 
  
Immunohistochemistry 
 
 Immunolabeling of cells was performed to determine total number of cells, total number 
of OL-lineage cells, and ER stress in each culture. Primary antibodies used included anti-Olig2 
(1:100; IBLInternational), anti-A2B5 (1:100; EMD Millipore), anti-O4 (1:25; EMD Millipore), 
and anti-CHOP (1:100; Cell Signaling Technology). Olig2 is a transcription factor expressed in 
all oligodendrocyte lineage cells, the detection of which requires fixed cells with permeabilized 
membranes. The lipid antigens A2B5 and O4 are expressed by early to late progenitor 
oligodendrocytes and late progenitor through mature oligodendrocyte cells, respectively, and 
together detect all OL-lineage cells when staining is performed in live cells. CHOP is a marker 
of cell stress and subsequent UPR induction, and antibodies for the protein indicate stressed cells 
when used in fixed cultures.  
 During live staining, cultures were blocked in 3% normal goat serum in HE (3% 
NGS/HE) for 10 minutes, after which they were exposed to the primary antibodies anti-A2B5 
(1:100) and anti-O4 (1:25) in 3% NGS/HE for 15 minutes. Cultures were washed in HE, fixed in 
4% PFA for 15 minutes, and washed in HE again. Cultures were incubated with Hoechst dye 
(1:200; Pierce Thermo) and fluorescein isothiocyanate (1:50; Jackson Labs) in 3% NGS/HE for 
45 minutes in the dark. Cultures were washed with HE, coverslipped, and stored at -30 °C. 
 During fixed staining, cultures were fixed in 4% paraformaldehyde for 30 minutes, 
washed with HE, and incubated with 5% NGS/0.3% Triton X-100 for 60 minutes. Cells were 
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washed with HE and the primary antibodies CHOP (1:100) and Olig2 (1:100) were added in 3% 
NGS for 1 hour. Cultures were washed with HE and incubated with Hoechst (1:200), fluorescein 
isothiocyanate (1:50), and gamma-Cy 3 (1:500; Jackson Labs) for 45 minutes in the dark. 
Cultures were washed with HE, coverslipped, and stored at -30 °C.  
 
Cell Visualization and Analysis 
 
 Cells were visualized using an Olympus IX70 optical microscope equipped with a Carl 
Zeiss camera. There were a total of 48 wells across the experiment, with between 2 and 10 wells 
per treatment condition. For each well, ten fields were randomly selected and imaged. Each 
image was a composite of photographs taken using the FITC, WU, and WG filters (for wells 
which had undergone live staining, the WG filter was not used). Using Zen 2012 software, the 
exposure time for each image was standardized.  
 
Image Analysis and Quantification 
  
 After all images were taken, blind counts were performed to determine: the number of 
Hoechst-positive cells per image in live- and fixed-staining conditions, giving the total number 
of cells in an image; the number of cells expressing A2B5/O4, giving the total number of OL-
lineage cells after live-staining; the number of cells expressing CHOP, giving the number of 
stressed cells after fixed-staining; and the number of cells expressing Olig2, giving the number 
of OL-lineage cells after fixed-staining. Based on these data, it was possible to investigate how 
the number of overall cells, OL-lineage cells, and markers of cell stress varied across treatments.   
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Results 
 
 In order to better understand the ER stress response in oligodendrocytes, we artificially 
induced protein-misfolding – and subsequent ER stress – through the administration of TU to 
mixed glial cultures grown in the OL differentiation media for a minimum of 24 hours. This 
exposure was split between chronic – with a lower dosage, for a longer period – and acute – with 
a higher dosage, for a shorter period – treatments, in order to analyze how cellular response 
would vary between mild but prolonged stress and intense but brief stress. In order to assess how 
mTOR inhibition alters the consequences of induced ER stress, the cultures were further 
subdivided into those given 1 µl/ml rapamycin on differentiation day 0 and controls. Altogether, 
this paradigm allowed us to ask – and answer – several critical questions about the mechanism 
and outcome of ER stress in oligodendrocytes. 
 
The Effects of Chronic TU Treatment on Cellular Survival 
 While our experimental paradigm gave us a variety of data to analyze, we began by 
investigating the effects of TU exposure in the absence of rapamycin pre-treatment. We further 
restricted our scope to chronic TU exposure, which consisted of of 24 hours at a concentration of 
1 µg/ml. We first quantified whether this exposure affected total cell count, as measured by 
Hoechst-positive cells. Because Hoechst staining was carried out in both live and fixed 
conditions, it was possible to cross validate the data as a way of gauging its accuracy. In each 
case, our results show that chronic TU exposure did not lead to a significant decrease in Hoechst-
positive cells (Figure 5). Having established that total cell counts were stable despite chronic TU 
exposure, we set out to determine whether cell type was changing by quantifying the percentage 
of all cells that expressed markers of OL-lineage. In this case, staining for both A2B5/O4 and 
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Olig2 revealed that chronic TU exposure did not reduce the number of OL-lineage cells (Figure 
6). More importantly, during chronic TU exposure the percentage of all cells that were labeled as 
OL-lineage did not change from control levels (Figure 7).  
 
The Effects of Acute TU Treatment on Cellular Survival 
 Having established the relatively innocuous effects of chronic TU exposure on mixed 
glial cultures, we next examined the effects of acute TU exposure on those cultures. During acute 
exposure, cell cultures were exposed to TU at a concentration of 10 µg/ml of 3 hours. As before, 
we initially assayed how that exposure altered total cell counts. Consistent with our findings 
from chronic TU conditions, the data indicate that acute TU exposure did not lead to a decrease 
in total cell count (Figure 8). However, the effects of acute TU exposure on OL-lineage cells in 
particular deviates from those of chronic TU exposure. Based on Olig2 expression in our 
cultures, acute TU exposure induced a significant drop in the number of OL-lineage cells – from 
126.2 to 76.5 (Figure 9) – and in the percentage of OL lineage cells – from 41.2% to 23.2% 
(Figure 10). Acute TU exposure also led to decreases in A2B5/O4-positive OL-lineage cell count 
from 66 to 52 (Figure 9), and in the overall percentage of A2B5/O4-positive cells from 26.8% to 
17.8% (Figure 10), but these decreases were narrowly insignificant. 
 
The Effects of mTOR Signaling on ER Stress 
 After investigating the effects of TU exposure in isolation, we proceeded to assess 
whether rapamycin pre-treatment altered those effects in any way. Half of our cultures received 1 
µl/ml of rapamycin prior to, and during, treatment. This allowed us to study whether mTOR 
inhibition altered the outcome of ER stress. Interestingly, rapamycin pre-treatment was found to 
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significantly increase the number of Hoescht-positive cells in all conditions for live staining and 
to significantly increase the number of Hoechst-positive cells in control and acute conditions 
during fixed staining (Figure 11, Figure 12). In the latter case, chronic cultures also showed an 
increase in total cell count with rapamycin pre-treatment, but this was narrowly insignificant 
(Figure 12). All told, these data implicate rapamycin as being a proliferative agent, whether or 
not cells are given ER stressors; possible mechanisms for this finding will be discussed in more 
detail below.  
 After observing the rapamycin-mediated increases in total cell count described above, we 
analyzed the effects of rapamycin pre-treatment on OL-lineage cells specifically. Our data show 
that rapamycin pre-treatment does not significantly alter the percentage of all cells that are 
A2B5/O4-postive, regardless of treatment condition (Figure 13). Olig2 staining largely agreed 
with these findings: control and chronic TU cultures did not show changes in OL-lineage cell 
percentages in response to rapamycin pre-treatment (Figure 14). However, acute TU cultures 
showed a significant decrease in OL-lineage cell percentage in response to rapamycin pre-
treatment, dropping from 23.2% to 15.0% (Figure 14). This decrease was unexpected, but one 
mechanism of how it may have arisen is outlined below.  
The Effects of Rapamycin Administration on Cellular Stress 
 Finally, we attempted to use a measure of ER stress, CHOP, in order to explore how the 
stress response was affected by rapamycin pre-treatment. We found that there was a high 
baseline stress in our control controls, with 48% of control cells expressing CHOP (Figure 15). 
Rapamycin pre-treatment led to an insignificant decrease in this figure, but without more data we 
cannot determine whether this is a robust finding (Figure 15). Cultures in the chronic TU 
exposure condition did not significantly differ from controls in their CHOP expression, and again 
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rapamycin was not shown to significantly change levels of CHOP (Figure 14). Acute TU 
cultures, however, had significantly fewer CHOP-expressing cells than control cultures – 32.2% 
relative to 48.3% – and rapamycin pre-treatment lowered that CHOP expression significantly 
further, to 19% (Figure 15). While further research is needed to understand this phenomenon, it 
would appear that the differential cellular response to acute versus chronic ER stress alters the 
effects of rapamycin pre-treatment and mTOR inhibition.  
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Discussion 
 
 Using antigens capable of describing cell populations and stress levels, this study aimed 
to improve our understanding of the phenomenon of ER stress in mixed glial cultures through 
TU-mediated stress induction. Through our observations of the differential effects of chronic and 
acute ER stress and the ways in which those effects are modified by the inhibition of the mTOR 
pathway, we can offer several insights on the mechanism and outcome of the mixed glial 
response to ER stress. The following will focus on what our data tell us about the inter- and 
intracellular response to ER stress, and if and how that response might best be optimized through 
artificial intervention.  
 Beginning with total cell count data, we were surprised to find that chronic and acute TU 
exposure did not decrease the total number of cells – as measured by both live and fixed staining 
– in cultures relative to controls (Figure 5, Figure 8). Because of its role as an ER stressor, TU 
has been implicated in elevated rates of cell death (Kato et al., 2012). We had expected to see the 
same trend in our mixed glial cultures. One possible explanation for this phenomenon is that 
mixed cultures offer protective intercellular benefits that are not available in enriched settings. 
Another possibility is that glia are differentially affected by ER stressors. For instance, astrocytes 
are five times more resilient than oligodendrocytes during oxidative stress, and are known to 
proliferate in response to inflammation (Johnstone et al., 2013; Penas et al., 2007; Sovrea and 
Bosca, 2013). Thus, while some cells may have died in response to chronic stress, others may 
have proliferated and effectively preserved total cell count. 
 To investigate whether these differential effects may have been relevant in our cultures, 
we consulted more detailed data on the cellular composition found in each treatment condition. 
Prior to our data collection, we had expected that TU treatment – acute and chronic alike – would 
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lead to drops in the percentage of OL-lineage cells, given that they are regarded as the most 
vulnerable cells in the CNS (Benjamins et al., 2013). However, we found that in our mixed glial 
cultures, chronic TU exposure did not lead to drops in OL-lineage cell count or percentage 
(Figure 5, Figure 6). This was especially puzzling given previous work in our lab using enriched 
OL-lineage cultures. In that research, TU administration at 2 µg/ml – only 1 µg/ml higher than 
the chronic concentration used in our experiment – significantly lowered cell counts as rapidly as 
three hours post-administration, with reductions in cell viability growing over the course of the 
next nine hours (McInnis, 2012; see Figure 4). Furthermore, the negative effects of TU 
administration were greater for young cells relative to mature ones (McInnis, 2012). Thus, the 
fact that the relatively immature OL-lineage cells in our cultures retained viability was especially 
surprising.  
 The most fundamental difference between this previous research and our own is our 
decision to use of mixed, instead of enriched, glial cultures. Thus, the fact that chronic TU 
exposure did not reduce the percentage of OL-lineage cells may have had to do with the glia 
surrounding those OL-lineage cells. In particular, it is possible that the effects of chronic TU 
treatment were overcome by the protective actions of astrocytes on OL-lineage-cells. Those 
protective actions are extensive: astrocytes produce antioxidants that can reduce oxidative stress, 
regulate glutamate levels that could otherwise induce excitotoxicity, and produce growth factors 
that are key for oligodendrocyte viability (Spampinato et al., 2015; Chen and Swanson, 2003). In 
the absence of astrocytes, oligodendrocytes are at elevated risks of damage: in mice, ablation of 
reactive astrocytes has been shown to lead to worse recovery in the form of more demyelination 
and reduced oligodendrocyte viability (Faulkner et al., 2004). In the presence of astrocytes, that 
risk drops: when media taken from enriched astrocyte cultures was added to enriched 
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oligodendrocyte cultures, the latter experienced less damage associated with hydrogen peroxide-
induced oxidative stress, serum starvation, and deprivation of oxygen or glucose (Arai and Lo, 
2010). Interestingly, these effects were diminished when the Ras/Raf/MEK/ERK and 
PI3K/AKT/mTOR signaling pathways were inhibited, suggesting that the astrocyte-mediated 
protection of oligodendrocytes involves interactions between these pathways and various cellular 
growth factors (Arai and Lo, 2010).  
 Indeed, the activity of the growth factors secreted by astrocytes may be a key factor in the 
survival of oligodendrocytes undergoing chronic TU stress. By providing neurotrophic support, 
the growth factors produced and distributed by astrocytes – including platelet-derived growth 
factor (PDGF), neurotrophin-3 (NT-3), nerve growth factor (NGF), leukemia inhibitory factor 
(LIF), ciliary neurotrophic factor (CNTF), and insulin-like growth factor-1 (IGF-1) – are thought 
to reduce ER stress (Nair et al., 2008; Kroeger et al., 2012). For instance, IGF-1 enhances the 
three arms of the UPR and increases the folding capacity of the ER, lowering the likelihood of 
cellular apoptosis (Novosyadlyy et al., 2008). Meanwhile, NGF and NT-3 each upregulate the 
Bcl-2 anti-apoptotic pathway, which is also the downstream target of the IRE1 arm of the UPR 
(Abram et al., 2009). Altogether, the growth factors secreted by astrocytes can help enhance and 
expand the oligodendrocyte response to ER stress. As a result, when that stress is not excessively 
severe, the presence of astrocytes can mitigate oligodendrocyte cell death as was seen in cultures 
given chronic TU exposure. 
 However, when stress is excessively severe, the protective effects of astrocytes on 
oligodendrocytes can be overwhelmed. This could explain what was seen in our data: while 
astrocytes may have prevented drops in viability for OL-lineage cells undergoing chronic TU 
stress, cultures undergoing acute TU stress showed drops in both the number and the percentage 
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of OL-lineage cells (Figure 9, Figure 10). This finding aligned with previous work our lab has 
done using enriched OPC cultures, in which a three-hour acute treatment with 10 µg/ml TU 
induced a significant level of cell death (McInnis, 2012; see Figure 3). It is possible that, in the 
case of mixed glial cultures, the growth factors secreted by astrocytes cannot provide support 
rapidly enough to overcome the effects of acute treatment. Growth factor production and 
secretion is a formidable process, and ramping up synthesis in response to stress is far from an 
instantaneous process. For instance, one study assessing changes in NGF production in response 
to hyperosmolar stress found that it took six hours for growth factor levels to increase 
significantly (Chang et al., 2008). While this finding comes from an experiment that differs from 
our own in several respects, it underscores the notion that growth factor production is a relatively 
gradual process. Thus, while chronic exposure offers a window of time during which astrocytes 
can begin to produce and secrete growth factors to protect oligodendrocytes, acute exposure may 
occur in too short a period for those measures to come to fruition. 
 Given that the protective effects of astrocytes can be overwhelmed by intense stress, the 
potential of mTOR inhibition to improve cell viability as a complementary protective measure is 
of particular interest. Our data show that rapamycin pre-treatment is generally protective for all 
treatment conditions, in that it increased total cell count as measured by live and fixed staining 
(Figure 11, Figure 12). This was somewhat unexpected – while we had hypothesized that 
rapamycin pre-treatment would be beneficial for cultures exposed to TU, we were surprised to 
observe that it also increased total cell count for control cultures. Since we anticipated that 
control cultures would be experiencing very little ER stress, we did not believe that mTOR 
inhibition would lead to any improvements in cell viability. However, given that both fixed and 
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live Hoechst stain data stand together in opposing this hypothesis, the proliferative effects of 
rapamycin appear to be quite robust even in the absence of TU. 
 One possible explanation of this phenomenon is that control cultures were experiencing 
significant levels of stress. This can be seen in the percentage of cells expressing CHOP, a 
marker of ER stress and UPR induction, which for control cultures is nearly 50% – a surprisingly 
high figure (Figure 15). Thus, baseline stress for all cultures may have been relatively high, 
potentially as a result of incubator variability, media composition, or other minor insults. If this 
was the case, then rapamycin pre-treatment may have been helpful for controls by helping to 
dampen the effects of that baseline stress by inhibiting excessive protein production and allowing 
for a return to equilibrium. Another potential reason for the efficacy of rapamycin pre-treatment 
is that our mixed cultures may have contained reactive microglia that induced inflammation and 
stress (Rock et al., 2004). By acting as an immunosuppressant, rapamycin may have limited the 
damage those microglia were able to cause and improved overall cell survival. 
 In addition to analyzing the effects of rapamycin of total cell counts, we investigated how 
rapamycin altered the percentage of cells that were OL-lineage. For A2B5/O4 and Olig2 
measures of OL-lineage cells, rapamycin pre-treatment did not lead to alterations in overall 
percentage for both control and chronic TU treatments (Figure 13, Figure 14). Since rapamycin 
increased overall cell count without changing the percentage of that cell count that was OL-
lineage, this implies that it led to proportional increases in OL-lineage cells and can be said to be 
a protective factor in these instances. However, while rapamycin pre-treatment did not change 
the percentage of total cells that expressed A2B5/O4 in acute TU cultures, it did lead to a 
significant drop in the percentage of cells expressing Olig2 in those cultures (Figure 13, Figure 
14). Without a greater variety of metrics, it is difficult to determine why rapamycin pre-treatment 
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would be less protective of oligodendrocytes in acute stress conditions relative to chronic stress 
conditions. One possibility is that, much like the protective effects exerted by astrocytes, the 
benefits due to rapamycin require time. Whereas in cases of chronic TU exposure the inhibition 
of mTOR may aid the UPR by reducing protein production, in cases of acute TU exposure the 
inhibition of mTOR may not be a sufficient step to improve cellular viability. 
 Our study also raises a potential issue concerning the use of rapamycin in combatting ER 
stress in mixed glial cultures. This particular issue relates to the protective effects of astrocytes 
that were discussed above, and which we suspect are at least in part exerted through growth 
factors. The effectiveness of those growth factors relies, at least in part, on both the 
Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways (Ballou and Zin, 2008). For instance, 
studies have found that the activity of IGF-1 and CNTF, both of which are neurotrophic growth 
factors secreted by astrocytes, require mTOR signaling (Lau et al., 2012; Yokogami et al., 2000; 
Kroeger et al., 2012). Thus, when rapamycin is used to inhibit mTOR and prevent protein 
translation, it might also interfere with the ability of astrocytes to protect oligodendrocytes via 
growth factor secretion.  
  As a final step in our attempt to understand the ER stress response of mixed glial 
cultures, we investigated CHOP expression and how it was altered by mTOR inhibition. Since 
CHOP is associated with ER stress, it was expected that TU administration – both chronic and 
acute – would increase CHOP expression relative to control levels, and that rapamycin pre-
treatment would decrease CHOP expression by ameliorating ER stress (Kuroiwa et al., 2014). 
However, the percentage of cells expressing CHOP did not increase in chronic conditions 
relative to control conditions, and exhibited a significant decrease in acute conditions relative to 
control conditions (Figure 15). This was unexpected, since studies have found that TU 
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administration significantly increases CHOP expression in oligodendrocytes (Lin et al., 2005; 
Mecha et al., 2012; Southwood et al., 2002). However, one possible explanation echoes our 
previous reasoning: during acute TU stress, cells had very little time to respond. In other words, 
the percentage of cells that expressed CHOP during acute TU stress may have remained low 
simply because of the brevity of the treatment period. For instance, one experiment that induced 
ER stress in vivo via ischemia found that CHOP mRNA expression began to increase six hours 
after injury, with production peaking 12 hours post-injury (Tajiri et al., 2004). Another study 
found that CHOP induction in oxygen- and glucose-deprived astrocytes led to CHOP mRNA 
induction that became visible at one hour, but which did not reach peak levels until six hours 
post-insult (Benavides et al., 2005). Thus, it appears that CHOP requires extended treatment 
periods in order to be produced on a significant scale, and is perhaps an inappropriate measure in 
cases of acute stress where treatment periods are too brief for CHOP production to reach peak 
levels. 
 The data amassed in this experiment allowed us to test several of our hypotheses. First, 
we found that chronic TU exposure was not sufficient to induce decreases in total cell count or 
OL-lineage cell count. We believe that this may be due to the protective effects of astrocytes in 
mixed cultures, which confirms our hypothesis that intercellular interactions in our cultures 
protected cells from toxicity. We further believe that these protective effects are mediated 
through growth factors, and thus require a generous amount of time to be felt. By extension, the 
extended time-course of astrocytic protective mechanisms relates to our findings concerning 
short-term, severe stress. We observed that acute TU exposure did induce drops in OL-lineage 
cell percentages. In this case, we believe that stress was intense and abbreviated enough to cause 
harm to oligodendrocytes before the protective growth factors secreted by astrocytes could be 
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produced and distributed in order to ameliorate that harm. This adds nuance to our hypothesis on 
the benefits provided to oligodendrocytes during ER stress by other glia, suggesting that it is 
only in conditions of modest stress that these benefits can stave off significant cell death. In our 
investigation of the efficacy of rapamycin inhibition of mTOR, we observed that pre-treatment 
with rapamycin increased total cell counts and preserved the percentage of cells that were OL-
lineage in both chronic and control conditions. During acute TU exposure, however, rapamycin 
pre-treatment could not prevent a significant drop in OL-lineage cell percentage, perhaps 
because that stress was too great to be remediated through the downregulation of protein 
production. Ultimately, we can partly accept our hypothesis on the utility of rapamycin inhibition 
of mTOR during ER stress, though with the caveat that extreme stress will render rapamycin less 
potent. Finally, we found that CHOP expression was not upregulated in cells that had been given 
TU treatments. We speculate that, for chronic TU treatment, astrocytic protection of 
oligodendrocytes prevented an increase in CHOP; for acute TU treatment, meanwhile, we 
believe that the time-course was too short to allow for measurable increases in CHOP 
expression. 
 While the data collected in our research are far from conclusive, they raise extremely 
interesting questions about the differences in ER stress response in mixed and enriched cell 
cultures. Our data suggest a critical role of astrocytes in improving oligodendrocyte viability in 
the face of long-term, moderate stress – a role that would be neglected in research assessing 
oligodendrocytes in isolation. In order to better understand how these effects are exerted, more 
research is needed. In the future, it would be invaluable to perform experiments similar to ours in 
enriched and mixed glial cultures simultaneously. By controlling for variability between 
experiments, this methodology would affirm whether or not mixed glial cultures truly 
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demonstrate improved viability in response to ER stress. Secondly, the mechanism of the 
protective effects offered by astrocytes during ER stress might better be understood by using 
growth factor receptor inhibitors. If it is true that astrocytes therapeutically act on 
oligodendrocytes via growth factors, then inhibiting their receptors should worsen 
oligodendrocyte viability during ER stress. By exploring these issues, we can better understand 
the role of astrocytes in oligodendrocyte viability during ER stress. This knowledge, in turn, is 
critical for understanding how ER stress and the demyelination that results from it might best be 
treated.  
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The development of OL-lineage cells from early progenitors to mature 
oligodendrocytes.  Notice that A2B5 and O4 (combined) or Olig2 staining will label OL-
lineage cells at any and all stages in development (Guardiola-Diaz et al., 2012). 
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Figure 2. The three signaling pathways of the UPR. The UPR comprises the ATF6 
pathway, the PERK pathway, and the IRE1 pathway (Walter and Ron, 2011).  
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Figure 3: The negative effects of three-hour, acute TU exposure at 10 µg/ml on the 
viability of oligodendrocyte precursor cells in enriched cultures. Greater concentrations of 
TU are associated with greater drops in cell viability as a result of increased ER stress 
(McInnis, 2012). 
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Figure 4: The negative effects of twelve-hour, chronic TU exposure at 2 µg/ml on the 
viability of oligodendrocyte precursor cells in enriched cultures. Longer durations of TU 
exposure were associated with greater drops in cell viability (McInnis, 2012). 
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Figure 5. Chronic exposure to TU failed to decrease the total number of Hoechst-
positive cells in mixed glial cultures. Mixed glial cultures were grown in the absence 
(control, n=16) or presence of tunicamycin (TU, 1 µg/ml, n=6) for 24 hours and stained under 
live (dark) and fixed (light) conditions with Hoechst to determine total cell count. Error bars 
represent standard error of the mean (SEM). 
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Figure 6. Chronic exposure to TU failed to decrease the number of OL-lineage cells in 
mixed glial cultures. Mixed glial cultures were grown in the absence (control, n=16) or 
presence of tunicamycin (TU, 1 µg/ml, n=6) for 24 hours and analyzed by immunolabeling 
for A2B5/O4 (dark) and Olig2 (light). Error bars represent SEM. 
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Figure 7. Chronic exposure to TU failed to decrease the percentage of total cells that 
were OL-lineage in mixed glial cultures. Mixed glial cultures were grown in the absence 
(control, n=16) or presence of tunicamycin (TU, 1 µg/ml, n=6) for 24 hours and analyzed by 
immunolabeling for A2B5/O4 (dark) and Olig2 (light). Error bars represent SEM. 
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Figure 8. Acute exposure to TU failed to decrease the total number of Hoechst-positive 
cells in mixed glial cultures. Mixed glial cultures were grown in the absence (control, n=16) 
or presence of tunicamycin (TU, 10 µg/ml, n=8) for 3 hours and stained under live (dark) and 
fixed (light) conditions with Hoechst to determine total cell count. Error bars represent SEM. 
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Figure 9. Acute exposure to TU significantly decreased the number of OL-lineage cells 
in mixed glial cultures. Mixed glial cultures were grown in the absence (control, n=16) or 
presence of tunicamycin (TU, 10 µg/ml, n=8) for 3 hours and analyzed by immunolabeling 
for A2B5/O4 (dark) and Olig2 (light). Acute TU exposure was associated with a significant 
decrease in Olig2-positive cells (p=0.0039) and an insignificant decrease in A2B5/O4-
positive cells (p=0.062). Error bars represent SEM. 
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Figure 10. Acute exposure to TU significantly decreased the percentage of OL-lineage 
cells in mixed glial cultures. Mixed glial cultures were grown in the absence (control, n=16) 
or presence of tunicamycin (TU, 10 µg/ml, n=8) for 3 hours and analyzed by immunolabeling 
for A2B5/O4 (dark) and Olig2 (light). Acute TU exposure was associated with a significant 
decrease in the percentage of Olig2-positive cells signaling (p=0.01) and an insignificant 
decrease in the percentage of A2B5/O4-positive cells (p=0.079). Error bars represent SEM. 
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Figure 11. Rapamycin pre-treatment significantly increased the total number of 
Hoechst-positive cells in mixed glial cultures for all treatment conditions, as measured 
by live staining. Mixed glial cultures were grown in the absence (control, n=6 for live 
staining) or presence of chronic (1 µg/ml for 24 hours, n=2 for live staining) and acute (10 
µg/ml for 3 hours, n=2 for live staining) tunicamycin and stained under live conditions with 
Hoechst to determine total cell count. Some cultures from each condition were pre-treated 
with rapamycin prior to treatment (control n=2, chronic n=2, acute n=2). Rapamycin pre-
treatment resulted in significant increases for control cultures (p=0.0025), chronic cultures 
(p=0.038), and acute cultures (p=0.035). Error bars represent SEM. 
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Figure 12. Rapamycin pre-treatment significantly increased the total number of 
Hoechst-positive cells in mixed glial cultures for control and acute TU conditions, as 
measured by fixed staining. Mixed glial cultures were grown in the absence (control, n=10 
for fixed staining) or presence of chronic (1 µg/ml for 24 hours, n=4 for fixed staining) and 
acute (10 µg/ml for 3 hours, n=6 for fixed staining) tunicamycin and stained under fixed 
conditions with Hoechst to determine total cell count. Some cultures from each condition 
were pre-treated with rapamycin prior to treatment (control n=6, chronic n=4, acute n=2). 
Rapamycin pre-treatment resulted in significant increases for control cultures (p=0.0056) and 
acute cultures (p=0.0023). Chronic cultures showed an insignificant increase in total cell 
count in response to rapamycin pre-treatment (p=0.10). Error bars represent SEM. 
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Figure 13. Rapamycin pre-treatment did not significantly alter the percentage of 
A2B5/O4-OL-lineage cells in mixed glial cultures for any TU treatment condition. Mixed 
glial cultures were grown in the absence (control, n=6 for live staining) or presence of chronic 
(1 µg/ml for 24 hours, n=2 for live staining) and acute (10 µg/ml for 3 hours, n=2 for live 
staining) tunicamycin and analyzed by immunolabeling for A2B5/O4. Some cultures from 
each condition were pre-treated with rapamycin prior to treatment (control n=2, chronic n=2, 
acute n=2). No variation in OL-lineage cell percentage was found as a result of rapamycin 
pre-treatment. Error bars represent SEM. 
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Figure 14. Rapamycin pre-treatment did not significantly alter the percentage of Olig2-
OL-lineage cells in mixed glial cultures for control and chronic TU conditions and 
lowered the percentage for acute conditions. Mixed glial cultures were grown in the 
absence (control, n=10 for fixed staining) or presence of chronic (1 µg/ml for 24 hours, n=4 
for fixed staining) and acute (10 µg/ml for 3 hours, n=6 for fixed staining) tunicamycin and 
analyzed by immunolabeling for Olig2. Some cultures from each condition were pre-treated 
with rapamycin prior to treatment (control n=6, chronic n=4, acute n=2). No variation in OL-
lineage cell percentage was found as a result of rapamycin pre-treatment for control and 
chronic conditions, though it was found to lead to a decrease in the percentage of Olig2-
positive cells under acute TU conditions (p=0.028). Error bars represent SEM. 
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Figure 15. Rapamycin pre-treatment reduced CHOP expression under acute conditions, 
but not under control and chronic conditions. Mixed glial cultures were grown in the 
absence (control, n=10 for fixed staining) or presence of chronic (1 µg/ml for 24 hours, n=4 
for fixed staining) and acute (10 µg/ml for 3 hours, n=6 for fixed staining) tunicamycin and 
analyzed by immunolabeling for CHOP. Some cultures from each condition were pre-treated 
with rapamycin prior to treatment (control n=6, chronic n=4, acute n=2). Rapamycin pre-
treatment reduced CHOP expression under acute TU conditions (p=0.033), while acute TU 
conditions with rapamycin pre-treatment exhibited less CHOP expression than chronic TU 
conditions with rapamycin pre-treatment (p=0.0497) and control conditions with rapamycin 
pre-treatment (p=0.019). Error bars represent SEM. 
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